"10.1371_journal.pone.0023720","plos one","2011-08-22T00:00:00Z","Jian feng Zhu; Zi jian Li; Guang sen Zhang; Kun Meng; Wen yong Kuang; Jin Li; Xin fu Zhou; Rui juan Li; Hong ling Peng; Chong wen Dai; Jian Kai Shen; Fan jie Gong; Yun xiao Xu; Su fang Liu","Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, Peoples Republic of China; Shenogen Biomedical Co, Ltd, Beijing, Haidian, Beijing, Peoples Republic of China","Conceived and designed the experiments: GsZ. Performed the experiments: JfZ ZjL WyK XfZ RjL HlP FjG SfL. Analyzed the data: JfZ GsZ ZjL KM. Contributed reagents/materials/analysis tools: KM JL CwD JKS YxX. Wrote the paper: GsZ.","Kun Meng and Jin Li are employees of Shenogen Biomedical Co, Ltd. The drug Icaritin was provided by Shenogen Biomedical Co, Ltd., who have the patent for the drug Icaritin (patent number 200710179673.8, date: 2007.12.17). There are no other products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","08","Jian feng Zhu","JFZ",14,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
